January 6, 2012 |
In a study suggesting that red wine might be the next big thing in breast cancer prevention, a study has found that women who drank just under two servings of red wine daily experienced hormonal changes that mimic the effects of a drug used to prevent malignant breast tumors from coming back. The study, published Friday in the Journal of Women's Health, found that consuming the same amount of white wine did not have the same effect in premenopausal women participating in the study.
January 25, 2011 |
The breast cancer drug tamoxifen may stall the progression of non-small cell lung cancer in those who take it after breast cancer treatment, a new study has found. Tamoxifen is the oldest of a wide array of medications that block the action of the hormone estrogen in the body. Researchers have found growing evidence in recent years that the majority of non-small cell lung cancers -- the most common form of lung cancer -- respond to estrogen with growth. So they wondered whether women taking tamoxifen as an adjunct to their breast cancer treatment might be less likely to develop or die of lung cancer.
February 2, 2012 |
The long-debunked idea that abortions can contribute to breast cancer is reappearing amid the outpouring of comments this week on Susan G. Komen for the Cure's decision to stop funding Planned Parenthood breast-health programs. Here's one comment on Komen's Facebook page: "Also! Breast cancer is linked to abortions!!! More and more studied are pointing to abortions for a huge risk factor for BC, why should SGK support something that raises the chances of what they wasn't destroyed?
July 26, 2011 |
Women with early-stage breast cancer have plenty of procedures and treatments to deal with. So it may come as welcome news that a large clinical trial has found no reason for doctors to perform two tests that were thought to help predict patient survival. Writing in the Journal of the American Medical Assn., the researchers say that the test results are meaningless. The tests in question involve looking for micrometastasis - microscopic evidence of a breast tumor's spread - in sentinel lymph nodes and in bone marrow.
December 10, 2010 |
The breast cancer drug pertuzumab when added to Herceptin improved the treatment of women with early-stage, HER-2 positive breast cancer, researchers reported Friday at the annual meeting of the San Antonio Breast Cancer Symposium . Pertuzumab is an experimental monoclonal antibody. In the study, 417 women received monoclonal antibody drug therapy before having surgery to remove the tumor. Some women also underwent chemotherapy. Adding pertuzumab to Herceptin -- which is also known by the generic name trastuzumab -- along with the chemotherapy drug docetaxel led to a tumor eradication rate of 46%. That is 50% better than the tumor eradication rate achieved with the standard therapy of docetaxel and Herceptin combined, said the authors of the paper, from the National Cancer Institute in Milan, Italy.
March 13, 2013 |
These days, thanks to advances in treatment and detection, millions of women survive breast cancer. But surviving the disease doesn't necessarily mean the entire battle is over, a population-based study of breast cancer survivors in Sweden and Denmark, published Wednesday in the New England Journal of Medicine , seems to suggest. Assessing a total of 2,168 women whose breast cancer was treated with radiation therapy between 1958 and 2001, a team of researchers found that women's chances of having a major coronary event - a heart attack, bypass surgery or heart disease death - rose in proportion with the radiation dose they received, even at the lower doses of radiation delivered in newer treatments.
October 28, 2010 |
For many women, the fight against breast cancer is public, with support from friends and family and frequent discussions with healthcare professionals about side effects and treatment. But part of that fight is intensely private -- rarely more so than when it affects their sex life. Certain chemotherapy drugs send women into early menopause within a few months. That, coupled, with hair loss and disfiguring mastectomies, leave some breast cancer survivors struggling to be intimate again, a new study finds.
October 14, 2011 |
Slogging through all the pink-themed products, promotions and publicity centered on breast cancer awareness month, it's been tough to find anything that stood out. But we did. We found this video from the Canadian-based organization Rethink Breast Cancer advertising an app that reminds you to do a breast self-exam. But this is no ordinary breast cancer video, and this is not your everyday app. The video begins with "Dr. " Rothaford Gray talking about how many women aren't checking regularly for breast cancer.